| Views | |
|---|---|
| Open-label use of an aliphatic polyamine immunomodulator in patients hospitalized with COVID-19 | 39 |
| December 2025 | January 2026 | February 2026 | March 2026 | April 2026 | May 2026 | June 2026 | |
|---|---|---|---|---|---|---|---|
| Open-label use of an aliphatic polyamine immunomodulator in patients hospitalized with COVID-19 | 1 | 1 | 0 | 0 | 1 | 10 | 0 |
| Views | |
|---|---|
| dic.2022-1-1.pdf | 30 |
| Views | |
|---|---|
| United States | 12 |
| Russia | 10 |
| Canada | 4 |
| Germany | 2 |
| United Kingdom | 2 |
| Belarus | 1 |
| Algeria | 1 |
| Ethiopia | 1 |
| Iraq | 1 |
| Japan | 1 |
| Views | |
|---|---|
| Moscow | 5 |
| Andover | 3 |
| Menlo Park | 3 |
| Ottawa | 3 |
| Arbil | 1 |
| Etobicoke | 1 |
| Hanoi | 1 |
| Hartlepool | 1 |
| Houston | 1 |
| Norwich | 1 |